ATAI

NASDAQ · Pharmaceuticals

Ataibeckley Inc

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.22

+0.12 (+2.93%)

As of Jun 24, 1:55 PM ET ·

ATAI News2 articles

AtaiBeckley Surges as Phase 3 Trials for Depression Drug Begin

AtaiBeckley shares jumped 7.8% to $4.14 after announcing the start of Phase 3 trials for its lead depression drug BPL-003, with results expected in early 2029.

Technology Jun 16

Jupiter Neurosciences Shares Plunge on $100M MDMA Deal and Dilutive Offering

Jupiter Neurosciences shares fell 37% to $0.205 after announcing a $100M licensing deal for MDMA drug ALA-002 and a $2M stock offering, with trading volume exceeding 230 million shares.